
Ligritinib (AB801) is an orally active AXL рецептор tyrosine киназы ингибитор. Ligritinib blocks the downstream signaling pathway by inhibiting the киназы activity of AXL. Ligritinib can be used in cancer research, especially in combination with chemotherapy for non-small клетка lung cancer (NSCLC).
Ligritinib (AB801) is an orally active AXL receptor tyrosine kinase inhibitor. Ligritinib blocks the downstream signaling pathway by inhibiting the kinase activity of AXL. Ligritinib can be used in cancer research, especially in combination with chemotherapy for non-small cell lung cancer (NSCLC).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.